Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, June 16, 2024 | Back issues
Courthouse News Service Courthouse News Service

18 States Sue Abbott Over TriCor Drug

WILMINGTON, DEL. (CN) - Eighteen states and the District of Columbia claim Abbott Laboratories illegally blocked generic competition through sham patent litigation and reformulating its cholesterol drug TriCor with only minor changes. Florida is lead complainant in this federal antitrust complaint.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.